Advanced oxidation protein products induce pre-osteoblast apoptosis through a nicotinamide adenine dinucleotide phosphate oxidase-dependent, mitogen-activated protein kinases-mediated intrinsic apoptosis pathway

Aging Cell

Volumn 17, Issue 4, 2018, Pages

  Zhu, Si Yuan ^a   Zhuang, Jing Shen ^a   Wu, Qian ^a   Liu, Zhong Yuan ^a   Liao, Cong Rui ^a   Luo, Shi Gan ^a   Chen, Jian Ting ^a   Zhong, Zhao Ming ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

advanced oxidation protein products; apoptosis; osteoblast; osteoporosis; oxidative stress; reactive oxygen species

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED OXIDATION PROTEIN PRODUCT; CASPASE 12; CASPASE 3; CASPASE 9; CYTOCHROME C; GLUCOSE REGULATED PROTEIN 78; MITOGEN ACTIVATED PROTEIN KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MAPK SIGNALING; MC3T3-E1 CELL LINE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; VERTEBRA BODY; 3T3 CELL LINE; ANIMAL; CELL CULTURE; METABOLISM; MOUSE; PATHOLOGY; SPRAGUE DAWLEY RAT;

3T3 CELLS; ADVANCED OXIDATION PROTEIN PRODUCTS; ANIMALS; APOPTOSIS; CELLS, CULTURED; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NADPH OXIDASES; OSTEOBLASTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85045386172     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12764     Document Type: Article

References (42)

1. Almeida, M., & O'Brien, C. A. (2013). Basic biology of skeletal aging: Role of stress response pathways. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 68, 1197–1208. https://doi.org/10.1093/gerona/glt079
2. Brown, C. (2017). Osteoporosis: Staying strong. Nature, 550, S15–S17. https://doi.org/10.1038/550s15a
3. Cagnol, S., & Chambard, J. C. (2010). ERK and cell death: Mechanisms of ERK-induced cell death–apoptosis, autophagy and senescence. FEBS Journal, 277, 2–21. https://doi.org/10.1111/j.1742-4658.2009.07366.x
4. Capeillere-Blandin, C., Gausson, V., Descamps-Latscha, B., & Witko-Sarsat, V. (2004). Biochemical and spectrophotometric significance of advanced oxidized protein products. Biochimica et Biophysica Acta, 1689, 91–102. https://doi.org/10.1016/j.bbadis.2004.02.008
5. Chen, J. R., Lazarenko, O. P., Blackburn, M. L., Mercer, K. E., Badger, T. M., & Ronis, M. J. (2015). p47phox-Nox2-dependent ROS signaling inhibits early bone development in mice but protects against skeletal aging. Journal of Biological Chemistry, 290, 14692–14704. https://doi.org/10.1074/jbc.m114.633461
6. Cummings, S. R., & Melton, L. J. (2002). Epidemiology and outcomes of osteoporotic fractures. Lancet, 359, 1761–1767. https://doi.org/10.1016/s0140-6736(02)08657-9
7. Ford, M. A., Bass, M., Zhao, Y., Bai, J. B., & Zhao, Y. (2011). Osteoporosis knowledge, self-efficacy, and beliefs among college students in the USA and China. Journal of Osteoporosis, 2011, 729219. https://doi.org/10.4061/2011/729219
8. Jilka, R. L., & O'Brien, C. A. (2016). The role of osteocytes in age-related bone loss. Current Osteoporosis Reports, 14, 16–25. https://doi.org/10.1007/s11914-016-0297-0
9. Jilka, R. L., Weinstein, R. S., Parfitt, A. M., & Manolagas, S. C. (2007). Quantifying osteoblast and osteocyte apoptosis: Challenges and rewards. Journal of Bone and Mineral Research, 22, 1492–1501. https://doi.org/10.1359/jbmr.070518
10. Kalousova, M., Skrha, J., & Zima, T. (2002). Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiological Research, 51, 597–604.
11. Kassem, M., & Marie, P. J. (2011). Senescence-associated intrinsic mechanisms of osteoblast dysfunctions. Aging Cell, 10, 191–197. https://doi.org/10.1111/j.1474-9726.2011.00669.x
12. Komori, T. (2016). Cell death in chondrocytes, osteoblasts, and osteocytes. International Journal of Molecular Sciences, 17, E2045. https://doi.org/10.3390/ijms17122045
13. Komosinska-Vassev, K., Olczyk, P., Winsz-Szczotka, K., Kuznik-Trocha, K., Klimek, K., & Olczyk, K. (2012). Age- and gender-related alteration in plasma advanced oxidation protein products (AOPP) and glycosaminoglycan (GAG) concentrations in physiological ageing. Clinical Chemistry and Laboratory Medicine, 50, 557–563. https://doi.org/10.1515/cclm.2011.789
14. Liu, S. X., Hou, F. F., Guo, Z. J., Nagai, R., Zhang, W. R., Liu, Z. Q., … Zhang, X. (2006). Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1156–1162. https://doi.org/10.1161/01.atv.0000214960.85469.68
15. Looker, A. C., Orwoll, E. S., Johnston, C. J., Lindsay, R. L., Wahner, H. W., Dunn, W. L., … Heyse, S. P. (1997). Prevalence of low femoral bone density in older U.S. adults from NHANES III. Journal of Bone and Mineral Research, 12, 1761–1768.
16. Marsche, G., Frank, S., Hrzenjak, A., Holzer, M., Dirnberger, S., Wadsack, C., … Oettl, K. (2009). Plasma-advanced oxidation protein products are potent high-density lipoprotein receptor antagonists in vivo. Circulation Research, 104, 750–757. https://doi.org/10.1161/circresaha.108.193169
17. Rastogi, R., Geng, X., Li, F., & Ding, Y. (2016). NOX activation by subunit interaction and underlying mechanisms in disease. Frontiers in Cellular Neuroscience, 10, 301. https://doi.org/10.3389/fncel.2016.00301
18. Reginster, J. Y., & Burlet, N. (2006). Osteoporosis: A still increasing prevalence. Bone, 38, S4–S9. https://doi.org/10.1016/j.bone.2005.11.024
19. Reppe, S., Datta, H. K., & Gautvik, K. M. (2017). Omics analysis of human bone to identify genes and molecular networks regulating skeletal remodeling in health and disease. Bone, 101, 88–95. https://doi.org/10.1016/j.bone.2017.04.012
20. Rottenberg, H., & Hoek, J. B. (2017). The path from mitochondrial ROS to aging runs through the mitochondrial permeability transition pore. Aging Cell, 16, 943–955. https://doi.org/10.1111/acel.12650
21. 2+: A control point for apoptosis. Science, 300, 135–139. https://doi.org/10.1126/science.1081208
22. Sendur, O. F., Turan, Y., Tastaban, E., & Serter, M. (2009). Antioxidant status in patients with osteoporosis: A controlled study. Joint Bone Spine, 76, 514–518. https://doi.org/10.1016/j.jbspin.2009.02.005
23. Shalini, S., Dorstyn, L., Dawar, S., & Kumar, S. (2015). Old, new and emerging functions of caspases. Cell Death and Differentiation, 22, 526–539. https://doi.org/10.1038/cdd.2014.216
24. Shen, H. M., & Liu, Z. G. (2006). JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radical Biology and Medicine, 40, 928–939. https://doi.org/10.1016/j.freeradbiomed.2005.10.056
25. Sun, J., Ming, L., Shang, F., Shen, L., Chen, J., & Jin, Y. (2015). Apocynin suppression of NADPH oxidase reverses the aging process in mesenchymal stem cells to promote osteogenesis and increase bone mass. Scientific Reports, 5, 18572. https://doi.org/10.1038/srep18572
26. Takeda, T., Matsushita, T., Kurozumi, M., Takemura, K., Higuchi, K., & Hosokawa, M. (1997). Pathobiology of the senescence-accelerated mouse (SAM). Experimental Gerontology, 32, 117–127. https://doi.org/10.1016/s0531-5565(96)00068-x
27. Tower, J. (2015). Programmed cell death in aging. Ageing Research Reviews, 23, 90–100.
28. Walters, J., Pop, C., Scott, F. L., Drag, M., Swartz, P., Mattos, C., … Clark, A. C. (2009). A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis. Biochemical Journal, 424, 335–345. https://doi.org/10.1042/bj20090825
29. Wauquier, F., Leotoing, L., Coxam, V., Guicheux, J., & Wittrant, Y. (2009). Oxidative stress in bone remodelling and disease. Trends in Molecular Medicine, 15, 468–477. https://doi.org/10.1016/j.molmed.2009.08.004
30. Weinstein, R. S., & Manolagas, S. C. (2000). Apoptosis and osteoporosis. American Journal of Medicine, 108, 153–164. https://doi.org/10.1016/s0002-9343(99)00420-9
31. Witko-Sarsat, V., & Descamps-Latscha, B. (1997). Advanced oxidation protein products: Novel uraemic toxins and pro-inflammatory mediators in chronic renal failure? Nephrology Dialysis Transplantation, 12, 1310–1312. https://doi.org/10.1093/ndt/12.7.1310
32. Witko-Sarsat, V., Friedlander, M., Capeillere-Blandin, C., Nguyen-Khoa, T., Nguyen, A. T., Zingraff, J., … Descamps-Latscha, B. (1996). Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney International, 49, 1304–1313. https://doi.org/10.1038/ki.1996.186
33. Witko-Sarsat, V., Friedlander, M., Nguyen, K. T., Capeillere-Blandin, C., Nguyen, A. T., Canteloup, S., … Descamps-Latscha, B. (1998). Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. Journal of Immunology, 161, 2524–2532.
34. Wu, Q., Zhong, Z. M., Pan, Y., Zeng, J. H., Zheng, S., Zhu, S. Y., & Chen, J. T. (2015). Advanced oxidation protein products as a novel marker of oxidative stress in postmenopausal osteoporosis. Medical Science Monitor, 21, 2428–2432. https://doi.org/10.12659/msm.894347
35. Wu, Q., Zhong, Z. M., Zhu, S. Y., Liao, C. R., Pan, Y., Zeng, J. H., … Chen, J. T. (2016). Advanced oxidation protein products induce chondrocyte apoptosis via receptor for advanced glycation end products-mediated, redox-dependent intrinsic apoptosis pathway. Apoptosis, 21, 36–50.
36. Xie, F., Sun, S., Xu, A., Zheng, S., Xue, M., Wu, P., … Bai, L. (2014). Advanced oxidation protein products induce intestine epithelial cell death through a redox-dependent, c-jun N-terminal kinase and poly (ADP-ribose) polymerase-1-mediated pathway. Cell Death & Disease, 5, e1006. https://doi.org/10.1038/cddis.2013.542
37. Yamamoto, Y., & Yamamoto, H. (2012). Interaction of receptor for advanced glycation end products with advanced oxidation protein products induces podocyte injury. Kidney International, 82, 733–735. https://doi.org/10.1038/ki.2012.163
38. Ye, W., Zhu, S., Liao, C., Xiao, J., Wu, Q., Lin, Z., & Chen, J. (2017). Advanced oxidation protein products induce apoptosis of human chondrocyte through reactive oxygen species-mediated mitochondrial dysfunction and endoplasmic reticulum stress pathways. Fundamental & Clinical Pharmacology, 31, 64–74.
39. Yeo, H., Beck, L. H., Thompson, S. R., Farach-Carson, M. C., McDonald, J. M., Clemens, T. L., & Zayzafoon, M. (2007). Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption. Journal of Biological Chemistry, 282, 35318–35327. https://doi.org/10.1074/jbc.m702435200
40. Zeng, J. H., Zhong, Z. M., Li, X. D., Wu, Q., Zheng, S., Zhou, J., … Chen, J. T. (2014). Advanced oxidation protein products accelerate bone deterioration in aged rats. Experimental Gerontology, 50, 64–71. https://doi.org/10.1016/j.exger.2013.11.014
41. Zhang, Y. B., Zhong, Z. M., Hou, G., Jiang, H., & Chen, J. T. (2011). Involvement of oxidative stress in age-related bone loss. Journal of Surgical Research, 169, e37–e42. https://doi.org/10.1016/j.jss.2011.02.033
42. Zhou, L. L., Cao, W., Xie, C., Tian, J., Zhou, Z., Zhou, Q., … Nie, J. (2012). The receptor of advanced glycation end products plays a central role in advanced oxidation protein products-induced podocyte apoptosis. Kidney International, 82, 759–770. https://doi.org/10.1038/ki.2012.184